MiNK Therapeutics, Inc. 是一家临床阶段的生物制药公司,致力于发现、开发和商业化用于治疗癌症及其他免疫介导疾病的同种异体、即用型恒定自然杀伤T细胞疗法。公司总部位于纽约州纽约市。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
营业支出
2026-06-30
$318.08万
2026-03-31
$284.57万
2025-12-31
$323.8万
2025-09-30
$294.6万
净利润
2026-06-30
-$312.82万
2026-03-31
-$274.23万
2025-12-31
-$260.21万
2025-09-30
-$288.77万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$-0.62
2026-03-31
$-0.57
2025-12-31
$-0.56
2025-09-30
$-0.65
息税折旧摊销前利润
2026-06-30
-$318.08万
2026-03-31
-$270.63万
2025-12-31
-$323.8万
2025-09-30
-$284.4万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$0
$0
$0
$0
营业支出
$318.08万
$284.57万
$323.8万
$294.6万
净利润
-$312.82万
-$274.23万
-$260.21万
-$288.77万
净利润率
--
--
--
--
每股收益
$-0.62
$-0.57
$-0.56
$-0.65
息税折旧摊销前利润
-$318.08万
-$270.63万
-$323.8万
-$284.4万
有效税率
--
--
--
--
常见问题
INKT is the ticker symbol for a publicly traded company listed on a U.S. stock exchange. It represents ownership shares in that business, allowing investors to participate in its financial performance. The specific company name, headquarters, and business focus are available on the INKT stock detail page. Because ticker symbols can be reused or changed, always confirm the current company identity and listing details directly from the latest INKT data displayed here.
The most current INKT stock price is shown on this page, typically with real-time or delayed quotes depending on the data feed. You can also check brokerage platforms, financial news sites, or the exchange where INKT is listed. For the exact latest price, bid-ask spread, and trading volume, refer to the live quote section above, as market prices change throughout the trading day.
INKT stock can be influenced by company-specific news such as earnings reports, product updates, management changes, and strategic announcements. Broader market conditions, sector trends, interest rates, and economic data also play a role. Additionally, investor sentiment, trading volume, and liquidity can amplify price movements. Because these factors interact constantly, the stock's price reflects a mix of fundamental and market-driven forces at any given time.
Valuation typically involves comparing INKT's market price to financial metrics like earnings, revenue, or book value. Common tools include the price-to-earnings (P/E) ratio, price-to-sales (P/S), and price-to-book (P/B) ratios. Investors may also compare these multiples to peers or the company's own historical averages. The actual valuation metrics for INKT are not provided here; check the latest financial data and ratios displayed on this page for current figures.
To buy INKT stock, you need a brokerage account that offers access to U.S. exchanges. Once funded, you can place a market or limit order for INKT shares during regular trading hours or, if supported, in extended sessions. Fractional shares may be available depending on your broker. Before trading, confirm any commissions, fees, and order types. The exact process and available features vary by brokerage platform.
Investing in INKT carries risks such as market volatility, sector-specific downturns, and company-specific challenges like competitive pressure, operational setbacks, or financial underperformance. Liquidity risk may also apply if trading volume is low. Additionally, broader economic factors, interest rate changes, and regulatory developments can affect the stock. These risks can lead to price declines, and the actual risk profile depends on INKT's current financial health and business circumstances.